Terms: = Liver cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Staging
15 results:
1. PET/CT imaging fibroblast activation protein in initial colorectal cancer: compared to 18 F-FDG PET/CT.
Dong Y; Sun P; Wu H; Zhong J; Cao M; Tang G; Zhou W
Nucl Med Commun; 2023 Nov; 44(11):1011-1019. PubMed ID: 37661771
[TBL] [Abstract] [Full Text] [Related]
2. C-reactive protein to albumin ratio predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
Tada T; Kumada T; Hiraoka A; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Hatanaka T; Kakizaki S; Shimada N; Kawata K; Tanaka T; Ohama H; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Arai T; Imai M; Naganuma A; Aoki T; Koizumi Y; Nakamura S; Joko K; Hiasa Y; Kudo M
Sci Rep; 2022 May; 12(1):8421. PubMed ID: 35589772
[TBL] [Abstract] [Full Text] [Related]
3. Development and validation of a nomogram based on stromal score to predict progression-free survival of patients with papillary thyroid carcinoma.
Tang J; Jiang S; Gao Q; Xi X; Gao L; Zhao R; Lai X; Zhang B; Jiang Y
Cancer Med; 2021 Aug; 10(16):5488-5498. PubMed ID: 34240816
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study.
Marasco G; Colecchia A; Bacchi Reggiani ML; Celsa C; Farinati F; Giannini EG; Benevento F; Rapaccini GL; Caturelli E; Di Marco M; Biasini E; Marra F; Morisco F; Foschi FG; Zoli M; Gasbarrini A; Baroni GS; Masotto A; Sacco R; Raimondo G; Azzaroli F; Mega A; Vidili G; Brunetto MR; Nardone G; Dajti E; Ravaioli F; Avanzato F; Festi D; Trevisani F;
Dig Liver Dis; 2021 Aug; 53(8):1011-1019. PubMed ID: 33353858
[TBL] [Abstract] [Full Text] [Related]
5. Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis.
Zhang XF; Xue F; Dong DH; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Lv Y; Pawlik TM
Ann Surg; 2021 Dec; 274(6):e1187-e1195. PubMed ID: 31972643
[TBL] [Abstract] [Full Text] [Related]
6. Optimized modification of the eighth edition of AJCC TNM staging system for resected pancreatic ductal adenocarcinoma.
Pu N; Yin L; Habib JR; Gao S; Hu H; Zhu Y; Wu Y; Yu J; Lou W
Future Oncol; 2019 Oct; 15(30):3457-3465. PubMed ID: 31460788
[No Abstract] [Full Text] [Related]
7. Efficacy of Percutaneous Thermal Ablation Combined With Transarterial Embolization for Recurrent Hepatocellular Carcinoma After Hepatectomy and a Prognostic Nomogram to Predict Survival.
Yuan Z; Wang Y; Hu C; Gao W; Zheng J; Li W
Technol Cancer Res Treat; 2018 Jan; 17():1533033818801362. PubMed ID: 30244651
[TBL] [Abstract] [Full Text] [Related]
8. Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy.
Liao R; Peng C; Li M; Li DW; Jiang N; Li PZ; Ding X; Wu Q; Du CY; Gong JP
Cancer Med; 2018 Apr; 7(4):1170-1182. PubMed ID: 29533004
[TBL] [Abstract] [Full Text] [Related]
9. Predicting the severity of liver cirrhosis through clinical parameters.
Zhang EL; Zhang ZY; Wang SP; Xiao ZY; Gu J; Xiong M; Chen XP; Huang ZY
J Surg Res; 2016 Aug; 204(2):274-281. PubMed ID: 27565061
[TBL] [Abstract] [Full Text] [Related]
10. Hepatocellular Carcinoma associated with Extra-hepatic Primary Malignancy: its Secular change, Clinical Manifestations and Survival.
Kee KM; Wang JH; Wang CC; Cheng YF; Lu SN
Sci Rep; 2016 Jul; 6():30156. PubMed ID: 27444261
[TBL] [Abstract] [Full Text] [Related]
11. A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: New proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases.
Ye L; Ye H; Zhou Q; Li Z; Lin Q; Tan L; Gao W; Fu Z; Zheng S; Chen R
Int J Surg; 2016 May; 29():108-17. PubMed ID: 27000717
[TBL] [Abstract] [Full Text] [Related]
12. Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
Qi X; Wang D; Su C; Li H; Guo X
Oncotarget; 2015 Jul; 6(21):18715-33. PubMed ID: 26243835
[TBL] [Abstract] [Full Text] [Related]
13. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
[TBL] [Abstract] [Full Text] [Related]
14. [Rectal non-Hodgkin lymphoma with concomitant rectal adenocarcinoma: a case report and literature review].
Song W; He YL; Han FH; Cai SR; Peng JJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):617-9. PubMed ID: 21866456
[TBL] [Abstract] [Full Text] [Related]
15. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
Zavaglia C; De Carlis L; Alberti AB; Minola E; Belli LS; Slim AO; Airoldi A; Giacomoni A; Rondinara G; Tinelli C; Forti D; Pinzello G
Am J Gastroenterol; 2005 Dec; 100(12):2708-16. PubMed ID: 16393224
[TBL] [Abstract] [Full Text] [Related]
